Core Viewpoint - The company is undergoing a transformation by converting its Shoe Carnival stores into Shoe Station stores, which is expected to yield positive results over the next few years [1]. Group 1: Company Transition - The transition from Shoe Carnival to Shoe Station is a strategic move aimed at enhancing the company's market position and operational efficiency [1].

Financial Data and Key Metrics Changes - For Q4 FY 2025, total net revenue was $42.8 million, a decrease from $43.9 million in Q4 FY 2024. Agribusiness revenue was $41.3 million compared to $42.5 million in the previous year [13][19] - The operating loss for Q4 FY 2025 was $11.1 million, compared to a loss of $2.8 million in Q4 FY 2024. The net loss applicable to common stock was $8.8 million, compared to a loss of $2 million in the same period last year [17][20] - For FY 2025, total net revenue was $159.7 million, down from $191.5 million in FY 2024, primarily due to decreased agribusiness revenues [19][20] Business Line Data and Key Metrics Changes - Agribusiness revenue for Q4 FY 2025 included $19.2 million in fresh packed lemon sales, significantly up from $8.4 million in Q4 FY 2024. Approximately 821,000 cartons of U.S. packed fresh lemons were sold at an average price of $23.33 per carton [13][14] - Avocado revenue was $300,000 in Q4 FY 2025, down from $8.9 million in Q4 FY 2024, with approximately 396,000 pounds sold at an average price of $0.79 per pound [15] - Orange revenue increased to $2.9 million in Q4 FY 2025 from $1.7 million in Q4 FY 2024, with 148,000 cartons sold at an average price of $19.67 per carton [16] Market Data and Key Metrics Changes - The company expects fresh lemon volumes of 4-4.5 million cartons and avocado volumes of 5-6 million pounds for FY 2026, indicating a strategic shift towards higher-demand products [24] - The transition to Sunkist is anticipated to enhance customer access and pricing stability, with a focus on contracted sales rather than open market sales [32] Company Strategy and Development Direction - The company is transforming its business model by reducing reliance on volatile lemon pricing and expanding into avocados and real estate development [5][9] - A planned organic recycling joint venture is expected to generate $4-$5 million in additional EBITDA starting in FY 2027 [7] - The company aims to achieve $10 million in cost savings in FY 2026, driven by operational restructuring and the Sunkist partnership [5][24] Management's Comments on Operating Environment and Future Outlook - Management highlighted the importance of the Sunkist partnership in improving cost structure and customer relationships, which is expected to yield financial benefits in FY 2026 [24] - The company anticipates a significant increase in avocado production capacity over the next few years, contributing to revenue growth [6][24] - Management expressed confidence in the long-term value of water rights and the potential for monetization through fallowing programs [39][46] Other Important Information - The company completed the sale of its Chilean assets for $15 million and is advancing the monetization of other non-strategic assets valued at approximately $40 million [8] - Long-term debt increased to $72.5 million as of October 31, 2025, compared to $40 million at the end of FY 2024 [22] Q&A Session Summary Question: Can you provide more details on the $10 million cost savings from the Sunkist partnership? - Management explained that the savings come from reduced sales and marketing costs and improved operational efficiencies, including renegotiated storage contracts [28][29] Question: How does the company plan to monetize its water rights? - Management discussed the complexities of water rights in water-scarce areas and the potential for monetization through conservation and fallowing programs [36][39] Question: What is the outlook for lemon pricing in the near term? - Management indicated that lemon prices are expected to stabilize, with a potential average price in the $20 range, depending on market conditions [72]

Core Viewpoint - Solventum has successfully completed the acquisition of Acera Surgical, enhancing its advanced wound care portfolio with innovative synthetic tissue matrix technology [1][2]. Financial Details - The acquisition was made for an upfront cash payment of $725 million, with potential contingent cash payments of up to $125 million based on future milestones [2]. - Acera is projected to generate approximately $90 million in sales in 2025 [3]. - The transaction is expected to be slightly dilutive to adjusted earnings per share (EPS) in 2026 but accretive starting in 2027 [3]. Strategic Implications - This acquisition marks a significant milestone in Solventum's three-phased transformation plan, expanding its MedSurg portfolio into the growing synthetic tissue matrices technology space in acute care settings [2][7]. - The addition of Acera is expected to accelerate Solventum's business transformation by acquiring a strategically aligned asset [7]. Advisory Information - Morgan Stanley & Co. LLC acted as the financial advisor for Solventum, while McDermott Will & Schulte LLP served as its legal advisor [4]. - Truist Securities provided financial advisory services to Acera, with Hogan Lovells US LLP as its legal advisor [4].

As filed with the Securities and Exchange Commission on December 17, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Nukkleus Inc. (Exact name of registrant as specified in its charter) Delaware 6770 38-3912845 (State or jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classification Code Number) Identification Number) 575 Fifth Ave., 14th Floor New ...

As filed with the Securities and Exchange Commission on December 17, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Nukkleus Inc. (Exact name of registrant as specified in its charter) Delaware 6770 38-3912845 (State or jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classification Code Number) Identification Number) 575 Fifth Ave., 14th Floor New ...

As filed with the Securities and Exchange Commission on December 17, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Nukkleus Inc. (Exact name of registrant as specified in its charter) Delaware 6770 38-3912845 (State or jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classification Code Number) Identification Number) 575 Fifth Ave., 14th Floor New ...

(Exact name of registrant as specified in its charter) As filed with the Securities and Exchange Commission on December 17, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Nukkleus Inc. Menachem Shalom Nukkleus Inc. Chief Executive Officer 575 Fifth Ave., 14th Floor New York, New York 10017 (212) 791-4663 (Name, address, including zip code, and telephone number, including area code, of agent ...

As filed with the Securities and Exchange Commission on December 17, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Nukkleus Inc. (Exact name of registrant as specified in its charter) Delaware 6770 38-3912845 (State or jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classification Code Number) Identification Number) 575 Fifth Ave., 14th Floor New ...

As filed with the Securities and Exchange Commission on December 17, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Nukkleus Inc. (Exact name of registrant as specified in its charter) (Address, including zip code, and telephone number, including area code, of Registrant's principal executive offices) Menachem Shalom Nukkleus Inc. Chief Executive Officer 575 Fifth Ave., 14th Floor New York, ...

Group 1 - J&J Snack Foods is implementing a transformation plan called Project Apollo, expected to generate at least $20 million in annualized operating income by 2026 [3][8] - The plan includes the closure of three production facilities by the end of Q1 2026, located in Atlanta, Holly Ridge (North Carolina), and Colton (California) [8] - The closures are part of a strategy to optimize the manufacturing footprint and are supported by investments to modernize and expand capacity for core products [8] Group 2 - The company has achieved an 8.3% reduction in distribution expenses year over year in Q4 2025, attributed to fewer internal transfers and improved truck utilization [4] - Project Apollo aims to yield $3 million in annualized savings from the ongoing revamp of the distribution system [5] - The overall transformation plan is designed to enhance efficiencies within the company's operations and improve the distribution network [6]